Study to Evaluate the Safety and Tolerability of a Once Daily Dose of 50 mg E2609 in Healthy Japanese Subjects
Clinical trial NCT03055962 · COMPLETED
Trial details
- NCT number
- NCT03055962
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-14
- Primary completion
- 2017-03-29
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.